Search
Ultragenyx Pharmaceutical Inc
RAREAdd to Watchlist
32.847USD
-0.543-1.63%
Market hours （ET）Quotes delayed by 15 min
3.23BMarket Cap
LossP/E TTM
Ultragenyx Pharmaceutical Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
673.00M
20.13%
EPS(YoY)
-5.83
7.24%
Analyst Rating
BUY
2026-06-30
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its total revenue reached 673.00M, with a year-on-year change of 20.13.
What are the current assets of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its current assets were 951.00M, with a year-on-year change of 16.38.
What are the total assets of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its total assets of Ultragenyx Pharmaceutical Inc were 1.53B, with a year-on-year change of 1.90.
What are the total liabilities of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its total liabilities of Ultragenyx Pharmaceutical Inc were 1.60B, with a year-on-year change of 29.31.
What is the total equity of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its total equity of Ultragenyx Pharmaceutical Inc was -73.00M, with a year-on-year change of -127.83.
What is the net investment of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its net investment of Ultragenyx Pharmaceutical Inc was 236.00M, with a year-on-year change of 1428.23.
What is the net financing of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its net financing of Ultragenyx Pharmaceutical Inc was 478.00M, with a year-on-year change of 19.73.
What is the Earnings Per Share (EPS) of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.83, with a year-on-year change of 7.24.
What is the net margin of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its net profit margin was -85.44, with a year-on-year change of 15.91.
What is the gross margin of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its gross margin was 83.80, with a year-on-year change of -2.90.
What is the debt-to-asset ratio of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its debt-to-asset ratio was 75.33, with a year-on-year change of 30.22.
What is the Return on Equity (ROE) of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its Return on Equity (ROE) was -656.03, with a year-on-year change of -205.84.
What is the Return on Assets (ROA) of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.89, with a year-on-year change of 0.34.
What is the operating profit of Ultragenyx Pharmaceutical Inc?
According to Ultragenyx Pharmaceutical Inc's FY2025 earnings report, its operating profit was -535.00M, with a year-on-year change of 0.18.